Citadel-MAGNUS
Advertising Networks · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
61 York St L 15, Sydney, New South Wales...Phone Number
+61 282340100Website
www.citadelmagnus.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Citadel-MAGNUS
Citadel-MAGNUS is an independent corporate and financial communication firm built on a reputation for delivering outstanding results for clients, with offices in Perth and Sydney. Our primary objective is to deliver a superior level of service to address the challenges facing companies in today's highly competitive business environment, through effective communication.Explore more
Citadel-MAGNUS Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Citadel-MAGNUS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Citadel-MAGNUS launches new products
Funding: Get notified immidiatlly once Citadel-MAGNUS has new funding data
Citadel-MAGNUS, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Citadel-MAGNUS
Check if Citadel-MAGNUS has recently received funding, and reach out quickly before it becomes old news!
Check out if Citadel-MAGNUS is spiking on competitors!
Earning: See what the market has to say on Citadel-MAGNUS recently announced quarterly report
Click to see if Citadel-MAGNUS had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Citadel-MAGNUS
Compare insights from companies similar to Citadel-MAGNUS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Citadel-MAGNUS is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Citadel-MAGNUS is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Citadel-MAGNUS.
Citadel-MAGNUS Tech Stack
A closer look at the technologies used by Citadel-MAGNUS
Citadel-MAGNUS News & Media
Citadel-MAGNUS is the highest ranked Australian transaction communication firm for fifth consecutive year: APAC Mergermarket League Tables
PERTH, Australia, Feb. 16, 2021 /PRNewswire/ -- Corporate and financial communication firm, Citadel-MAGNUS, has achieved a top four ranking on deal count and deal volume for the Asia-Pacific region (excl. Japan) in the 2020 PR Advisors global and regional league tables from Mergermarket. The fourth placed ranking across both measures consolidates Citadel-MAGNUS as the leading transaction communication advisory firm in Australia for the fifth consecutive year. Based on Mergermarket's assessment cImmutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
SYDNEY, Australia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced new positive interim data from its TACTI-mel Phase I clinical trial, presented at the 33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in Washington, D.C., U.S.Immutep Announces Data Presentations at Upcoming Industry Conferences
SYDNEY, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced that clinical data on the Company’s lead product candidate eftilagimod alpha (“efti” or “IMP321”), a soluble LAG-3Ig fusion protein based on the LAG-3 immune control mechanism, will be presented at several industry conferences in October, November and Decemb
Read more news
Top Advertising Networks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Citadel-MAGNUS
Sign Up For FreeTo access detailed company insights
Citadel-MAGNUS is an independent corporate and financial communication firm built on a reputation for delivering outstanding results for clients, with offices in Perth and Sydney. Our primary objective is to deliver a superior level of service to address the challenges facing companies in today's highly competitive business environment, through eff... Read More
